The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution.Hamilton, J.A., Steinrauf, L.K., Braden, B.C., Liepnieks, J., Benson, M.D., Holmgren, G., Sandgren, O., Steen, L.
(1993) J Biol Chem 268: 2416-2424
- PubMed: 8428915
- Primary Citation of Related Structures:
1ETB, 1ETA, 1TTC, 1TTB, 1TTA
- PubMed Abstract:
- X-Ray Crystal Structure of the Ala 109(Right Arrow)Thr Variant of Human Transthyretin which Produces Euthyroid Hyperthyroxinemia
Steinrauf, L.K., Hamilton, J.A., Braden, B.C., Murrell, J.R., Benson, M.D.
(1993) J Biol Chem 268: 2425
- Alteration in Molecular Structure which Results in Disease: The met 30 Variant of Human Plasma Transthyretin
Hamilton, J.A., Steinrauf, L.K., Liepnieks, J.J., Benson, M.D., Holmgren, G., Sandgren, O., Steen, L.
(1992) Biochim Biophys Acta 139: 9
The x-ray crystal structures of normal human transthyretin (prealbumin) and the amyloidogenic Val-30-Met variant have been refined at 1.7-A resolution to R-values of 0.168 and 0.179, respectively, for 19,882 and 20,362 reflections (Fobs > 2.0 sigma). Standard deviations for stereochemical parameters are 0 ...
The x-ray crystal structures of normal human transthyretin (prealbumin) and the amyloidogenic Val-30-Met variant have been refined at 1.7-A resolution to R-values of 0.168 and 0.179, respectively, for 19,882 and 20,362 reflections (Fobs > 2.0 sigma). Standard deviations for stereochemical parameters are 0.018 and 0.022 A for bond distances, 0.030 and 0.038 A for angle distances, and 0.035 and 0.070 A for planar 1-4 distances. The newly refined normal structure shows improvement over the original structure of Blake and Swan (Blake, C. C. F., and Swan, I. D. A. (1971) J. Mol. Biol. 61, 217-224) in stereochemistry and in the conformation of the loop regions. Residues Arg-103, Thr-123, Asn-124, and Pro-125 have now been resolved, and residues 1-9 and 126-127 have been modeled with the aid of simulated annealing refinement. The functional form of transthyretin is a tetramer, having a cylindrical cavity which will bind thyroxine and an exterior binding site for the complex of retinol with retinol-binding protein. The monomer is a beta barrel flattened to become more like a sandwich with residue 30 in the interior. The methionyl for valyl substitution forces the beta sheets of the monomer as much as 1 A apart, resulting in a distortion of the thyroxine-binding cavity, in agreement with the independent observations that the Met-30 variant has low affinity for thyroxine.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis 46202-5122.